Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors
Shong Lau1, Daniella Rylander Ottosson1, Johan Jakobsson1
1Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, BMC A11, 221 84 Lund, Sweden.
Cell Reports
|December 9, 2014
Summary
Human fibroblasts can be directly converted into functional neurons. This study presents a self-regulated system using microRNA-124 for safer, clinical-grade induced neuron generation for cell therapy.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Molecular Biology
Background:
- Direct reprogramming of human fibroblasts into functional neurons bypasses stem cell stages.
- This offers potential for patient-specific neuron generation for therapeutic applications.
- Existing methods face challenges with viral transgene integration and control.
Purpose of the Study:
- To present an improved, self-regulated system for direct neural conversion of human fibroblasts.
- To enhance safety and suitability for clinical applications.
- To overcome limitations of previous viral vector-based reprogramming systems.
Main Methods:
- Utilized microRNA-124 (miR-124) to regulate neural reprogramming genes in human fibroblasts.
- Implemented a nonintegrative system by combining regulated gene expression with integrase-deficient vectors.
- Developed a self-regulating conversion process where cells turn off reprogramming genes upon achieving neuronal fate.
Main Results:
- Achieved direct conversion of human fibroblasts into functional neurons.
- The miR-124-regulated system ensures self-termination of reprogramming gene expression.
- The use of integrase-deficient vectors provides a nonintegrative and safer reprogramming approach.
- The developed system is suitable for clinical use, minimizing risks associated with viral integration.
Conclusions:
- The novel self-regulated, nonintegrative system represents a significant advancement for generating induced neurons.
- This improved method enhances the safety profile for clinical applications in cell therapy.
- The findings pave the way for developing patient-specific neuronal therapies using direct reprogramming.


